Role of Dab2IP in Brain Development
Dab2IP 在大脑发育中的作用
基本信息
- 批准号:7032609
- 负责人:
- 金额:$ 35.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-01 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The mammalian brain is formed through a series of intricately orchestrated events whereby neurons born in germinal zones migrate great distances to reach their final positions and form specific connections. Abnormalities in neuronal migration and positioning are believed to be responsible in part for disorders such as lissencephaly, pediatric epilepsy, schizophrenia and autism. Recent genetic studies in mice have identified a key signaling pathway that controls cell positioning and formation of laminated structures throughout the mammalian brain. Mice with disruptions in reelin, disabled-1 (Dab1), or both very low-density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2) genes exhibit nearly identical histopathological abnormalities. Reelin is an extracellular protein that directly binds to the lipoprotein receptors and induces tyrosine phosphorylation of Dab1. Dab1 is an intracellular adapter protein that is required for Reelin signaling. The long-range goal of this project is to identify molecular components downstream of Dab1 in the Reelin signaling pathway and to understand the mechanism by which Reelin controls neuronal positioning, dendritic maturation, and synaptic function. Using a yeast two-hybrid strategy, it was found that Dab1 interacts with amyloid precursor family proteins, protocadherin-18 and the novel GTPase activating protein Dab2 interacting protein (Dab2IP). The deduced amino acid sequence of Dab2IP encodes a Ras GAP related domain and several protein-protein interaction domains, including an NPxY PTB-interacting motif. It is hypothesized that Dab2IP functions as a regulator of GTPases and, by virtue of its interaction with Dab1 and other intracellular proteins, is the downstream effector in the Reelin signaling pathway. The specific aims of this proposal are to: 1) Characterize the activity, regulation and cellular function of Dab2IP; 2) Determine if Dab2IP plays a critical role in Reelin signaling; 3) Characterize the Dab2IP-P1-/- mice which have recently been generated in this laboratory. Understanding the biological function of Dab2IP and its role in Reelin signaling will provide valuable insight into the molecular mechanisms of neuronal migration, cell positioning and dendrite maturation during brain development.
描述(由申请人提供):哺乳动物的大脑是通过一系列精心策划的事件形成的,这些事件在生发区域中出生的神经元迁移了很大的距离以达到其最终位置并形成特定的连接。据信神经元迁移和定位的异常是部分造成诸如Lissphaly,小儿癫痫,精神分裂症和自闭症等疾病的原因。小鼠的近期遗传研究已经确定了一个关键的信号通路,该途径控制整个哺乳动物大脑的细胞定位和形成的细胞定位和形成。 reelin,disabled-1(DAB1)或非常低密度脂蛋白受体(VLDLR)和珠脂蛋白E受体2(APOER2)基因的小鼠表现出几乎相同的组织病理学异常。 reelin是一种直接与脂蛋白受体结合并诱导DAB1酪氨酸磷酸化的细胞外蛋白。 DAB1是reelin信号所需的细胞内适配器蛋白。该项目的远距离目标是确定reelin信号通路中DAB1下游的分子成分,并了解Reelin控制神经元定位,树突成熟和突触功能的机制。使用酵母双杂交策略,发现DAB1与淀粉样蛋白前体蛋白,Protocadherin-18和新型GTPase激活蛋白DAB2相互作用蛋白(DAB2IP)相互作用。 DAB2IP的推导氨基酸序列编码RAS间隙相关结构域和几个蛋白质 - 蛋白质相互作用结构域,包括NPXY PTB相互作用基序。假设DAB2IP充当GTPase的调节剂,并且由于它与DAB1和其他细胞内蛋白的相互作用是Reelin信号通路中的下游效应子。该建议的具体目的是:1)表征DAB2IP的活性,调节和细胞功能; 2)确定dab2ip在reelin信号传导中是否起关键作用; 3)表征该实验室最近生成的DAB2IP-P1 - / - 小鼠。了解DAB2IP的生物学功能及其在reelin信号传导中的作用将提供对脑发育过程中神经元迁移,细胞定位和树突成熟的分子机制的宝贵见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
RAMIN HOMAYOUNI的其他基金
Regulation of mitochondrial dehdyrogenases and neuronal NADH levels via interaction of NIPSNAP1 and APP intracellular domain
通过 NIPSNAP1 和 APP 胞内域相互作用调节线粒体脱氢酶和神经元 NADH 水平
- 批准号:93180849318084
- 财政年份:2017
- 资助金额:$ 35.81万$ 35.81万
- 项目类别:
Role of Dab2IP in Brain Development
Dab2IP 在大脑发育中的作用
- 批准号:72442827244282
- 财政年份:2006
- 资助金额:$ 35.81万$ 35.81万
- 项目类别:
Role of Dab2IP in Brain Development
Dab2IP 在大脑发育中的作用
- 批准号:76639627663962
- 财政年份:2006
- 资助金额:$ 35.81万$ 35.81万
- 项目类别:
Role of Dab2IP in Brain Development
Dab2IP 在大脑发育中的作用
- 批准号:74680767468076
- 财政年份:2006
- 资助金额:$ 35.81万$ 35.81万
- 项目类别:
相似国自然基金
载脂蛋白E模拟肽(6KApoEp)激活LRP1抑制CypA/NF-κB/MMP-9通路降低脑出血后病灶周围血脑屏障通透性
- 批准号:82260244
- 批准年份:2022
- 资助金额:32 万元
- 项目类别:地区科学基金项目
载脂蛋白E对人干细胞稳态和衰老的调控作用及机制
- 批准号:81901433
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
纳米脂质颗粒ApoE-rHDL靶向调控MDSCs重塑免疫微环境在胶质母细胞瘤免疫治疗中的作用与机制研究
- 批准号:81902529
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
SR蛋白在大脑脂代谢以及阿尔茨海默病病理过程中的作用机制研究
- 批准号:31871082
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
基于多模态磁共振成像研究APOEε4和CLU交互作用对健康人海马的调控机制
- 批准号:81801686
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Treating neurotoxicity and cognitive deficits due to hyperphosphorylated tau.
治疗由过度磷酸化 tau 引起的神经毒性和认知缺陷。
- 批准号:1081539910815399
- 财政年份:2023
- 资助金额:$ 35.81万$ 35.81万
- 项目类别:
The effects of APOE genotype in homeostatic microglial function in preclinical APOE mouse model
APOE基因型对临床前APOE小鼠模型稳态小胶质细胞功能的影响
- 批准号:1082861310828613
- 财政年份:2023
- 资助金额:$ 35.81万$ 35.81万
- 项目类别:
Investigating cell-type specific convergence of APOE and ABCA7 lipid dysregulation in Alzheimer’s disease
研究阿尔茨海默病中 APOE 和 ABCA7 脂质失调的细胞类型特异性趋同
- 批准号:1090099310900993
- 财政年份:2023
- 资助金额:$ 35.81万$ 35.81万
- 项目类别:
Single-cell transcriptomic and epigenomic analysis of brain cell vulnerabilities to tauopathies in early AD impacted brain regions
早期 AD 影响大脑区域脑细胞对 tau 蛋白病变脆弱性的单细胞转录组和表观基因组分析
- 批准号:1066701610667016
- 财政年份:2023
- 资助金额:$ 35.81万$ 35.81万
- 项目类别:
Integrative Pathways to Cognitive, Affective, and Brain Health
认知、情感和大脑健康的综合途径
- 批准号:1070736210707362
- 财政年份:2022
- 资助金额:$ 35.81万$ 35.81万
- 项目类别: